EKSO Q4 2018 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$30M

Q4 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M+34.4% YoY

Gross Profit

$1M45.2% margin

Operating Income

-$5M-155.9% margin

Net Income

-$4M-125.3% margin

EPS (Diluted)

$-0.99

QoQ Revenue Growth

+29.3%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$692,000

Balance Sheet

Total Assets

$18M

Total Liabilities

$15M

Stockholders' Equity

$3M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+34.4%
Gross Profit	$1M	$777,000	+91.9%
Operating Income	-$5M	-$8M	+35.3%
Net Income	-$4M	-$9M	+54.0%

Revenue Segments

Product

$2M73%

Service

$666,00020%

Product and Service, Other

$227,0007%

Geographic Segments

UNITED STATES

$2M62%

Non-US

$1M38%